JILL ROULEAU: Open Payments
NPI 1194158055 · WESTON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$591 in 23 payments from 10 companies in 2025. Trend: 2023 $560 · 2024 $613 · 2025 $591
Food & beverage: $467Education: $124
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 7 | $220 |
| Celgene Corporation | 5 | $100 |
| GENZYME CORPORATION | 2 | $92 |
| PFIZER INC. | 2 | $37 |
| Daiichi Sankyo Inc. | 1 | $28 |
| TAIHO ONCOLOGY, INC. | 1 | $26 |
| Janssen Pharmaceuticals, Inc | 2 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
| Incyte Corporation | 1 | $24 |
| E.R. Squibb & Sons, L.L.C. | 1 | $16 |
Products named: REBLOZYL, DARZALEX, TALVEY, WAYRILZ, Enhertu, LONSURF, ALUNBRIG, MONJUVI.
Industry payments across FL — which companies pay providers there.
